AstraZeneca Cash on Hand 1992-2025 | AZN

AstraZeneca cash on hand from 1992 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.

AstraZeneca cash on hand for the quarter ending June 30, 2025 was $7.203B, a 1.39% increase year-over-year.
AstraZeneca cash on hand for 2024 was $5.708B, a 6.09% decline from 2023.
AstraZeneca cash on hand for 2023 was $6.078B, a 6.38% decline from 2022.
AstraZeneca cash on hand for 2022 was $6.492B, a 0.17% increase from 2021.

Fatal error: Uncaught TypeError: number_format(): Argument #1 ($num) must be of type float, string given in /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php:2773 Stack trace: #0 /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php(2773): number_format() #1 /var/www/html/macrotrends/public_html/assets/php/url_router.php(168): include('...') #2 {main} thrown in /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php on line 2773

AstraZeneca Annual Cash on Hand (Millions of US $)
2024	$5,708
2023	$6,078
2022	$6,492
2021	$6,481
2020	$8,134
2019	$6,254
2018	$5,938
2017	$4,582
2016	$5,929
2015	$6,855
2014	$7,176
2013	$10,053
2012	$8,555
2011	$11,844
2010	$12,559
2009	$11,402
2008